CTRI/2024/03/064848尚未招募3 期
A comparative study of Vilanterol/Fluticasone furoate with Formoterol/Budesonide in the management of stable bronchial asthma - nil
SRM College of Pharmacy0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. patients with stable bronchial asthma
- •2. patients who already receiving prescription with formoterol /budesonide
排除标准
- •1. patients with asthma /copd overlap
- •2. patients with bronchiectasis
- •3. patients with allergic bronchopulmonary aspergillosis
- •4.history of smoking
- •5.pregnancy
研究者
相似试验
进行中（未招募）
Unknown
To know whether the newer drug combination i.e. Vilanterol-Fluticasone is better than the conventionally use combination Formoterol-Budesonide in terms of effectiveness in controlling asthma symptoms and improving lung function in stable asthma patients or not.CTRI/2023/05/052174Department of Pulmonary, Critical Care and sleep Medicine
已完成
1 期
Relovair PD PK in Chinese Healthy SubjectsAsthmaNCT01711463GlaxoSmithKline16
撤回
4 期
The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on AsthmaAsthmaNCT03363191GlaxoSmithKline
已完成
3 期
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsAsthmaNCT01147848GlaxoSmithKline810
已完成
3 期
Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent AsthmaticsAsthmaNCT01134042GlaxoSmithKline587